南方财经12月30日电，科陆电子（002121.SZ）公告，预计2026年度与关联方发生日常关联交易总金额 为39,300万元。主要包括向美的集团、会通新材、盈峰环境、车电网络等关联方采购原材料、商品，金 额合计9,100万元；向上述关联方销售产品及提供电力工程施工等服务，金额合计28,500万元；接受美的 集团提供的软件开发服务800万元；向美的集团和车电网络提供租赁及物业服务900万元。 ...

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Baihua Pharmaceutical, which closed at 7.06 yuan with a PE ratio of 65.29, marking a new low in 21 days, and a total market capitalization of 2.712 billion yuan [1] - Baihua Pharmaceutical operates in the medical services sector, which has an average PE ratio of 38.69 and a median of 38.36, placing the company at the 34th position in the industry ranking [1] - As of the first quarter of 2025, six institutions hold shares in Baihua Pharmaceutical, with a total of 38.7143 million shares valued at 2.78 million yuan [1] Group 2 - Baihua Pharmaceutical's main business includes early drug discovery and screening, drug CMC development, clinical trials, registration applications, BE/PK bio-sample analysis, and pharmacy testing services, providing a comprehensive outsourcing and technology transfer service [1] - The latest financial results for the first quarter of 2025 show that the company achieved an operating income of 96.9172 million yuan, a year-on-year increase of 6.65%, and a net profit of 20.7209 million yuan, with a slight year-on-year increase of 0.28% and a gross profit margin of 51.41% [1]